Literature DB >> 23352270

Increasing glucose load while maintaining normoglycemia does not evoke neuronal damage in prolonged critically ill rabbits.

Romain Sonneville1, Heleen M den Hertog, Sarah Derde, Fabian Güiza, Inge Derese, Greet Van den Berghe, Ilse Vanhorebeek.   

Abstract

BACKGROUND & AIMS: Preventing severe hyperglycemia with insulin reduced the neuropathological alterations in frontal cortex during critical illness. We investigated the impact of increasing glucose load under normoglycemia on neurons and glial cells.
METHODS: Hyperinflammatory critically ill rabbits were randomized to fasting or combined parenteral nutrition containing progressively increasing amounts of glucose (low, intermediate, high) within the physiological range but with a similar amount of amino acids and lipids. In all groups, normoglycemia was maintained with insulin. On day 7, we studied the neuropathological alterations in frontal cortex neurons, astrocytes and microglia, and MnSOD as marker of oxidative stress.
RESULTS: The percentage of damaged neurons was comparable among all critically ill and healthy rabbits. Critical illness induced an overall 1.8-fold increase in astrocyte density and activation status, largely irrespective of the nutritional intake. The percentage of microglia activation in critically ill rabbits was comparable with that in healthy rabbits, irrespective of glucose load. Likewise, MnSOD expression was comparable in critically ill and healthy rabbits without any clear impact of the nutritional interventions.
CONCLUSIONS: During prolonged critical illness, increasing intravenous glucose infusion while strictly maintaining normoglycemia appeared safe for neuronal integrity and did not substantially affect glial cells in frontal cortex.
Copyright © 2013 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Astrocyte; Critical illness; GAPDH; GFAP; GLUT-4; Glucose load; IV; Microglia; MnSOD; Neuron; Normoglycemia; glial fibrillary acidic protein; glucose transporter-4; glyceraldehyde-3-phosphate dehydrogenase; intravenous; manganese superoxide dismutase

Mesh:

Substances:

Year:  2013        PMID: 23352270     DOI: 10.1016/j.clnu.2013.01.003

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  2 in total

1.  Blood glucose control in the ICU: don't throw out the baby with the bathwater!

Authors:  Jan Gunst; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2016-05-09       Impact factor: 17.440

Review 2.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.